ArticleClinical and diagnostic laboratory immunology1999

The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.

K C Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.